Kiniksa Pharmaceuticals Partners with GRAMMY® Award-Winning Singer-Songwriter, Carly Pearce, in Expansion of Life DisRPted™ Campaign to Drive Awareness of Recurrent Pericarditis
Kiniksa Pharmaceuticals (Nasdaq: KNSA) has partnered with GRAMMY Award-winning singer-songwriter Carly Pearce to expand its Life DisRPted™ campaign, focusing on raising awareness for recurrent pericarditis. The campaign aims to promote early diagnosis and treatment of this rare, chronic autoinflammatory disease. Pearce, who was diagnosed with recurrent pericarditis while on tour in May 2024, joins the initiative to support patients and caregivers affected by the condition.
The campaign serves as a platform to encourage both patients and healthcare providers to recognize signs of recurrent pericarditis and develop appropriate treatment plans to minimize its impact on patients' lives. More information about the campaign and the condition can be found at LifeDisRPted.com.
Kiniksa Pharmaceuticals (Nasdaq: KNSA) ha stretto una collaborazione con Carly Pearce, cantautrice vincitrice di un premio GRAMMY, per ampliare la sua campagna Life DisRPted™, focalizzandosi sull'aumento della consapevolezza riguardo la pericardite ricorrente. La campagna si propone di promuovere una diagnosi precoce e un trattamento per questa rara malattia autoinfiammatoria cronica. Pearce, diagnostica con pericardite ricorrente mentre era in tour nel maggio 2024, partecipa all'iniziativa per sostenere i pazienti e i caregiver colpiti da questa condizione.
La campagna funge da piattaforma per incoraggiare sia i pazienti che i fornitori di assistenza sanitaria a riconoscere i segnali di pericardite ricorrente e sviluppare piani di trattamento appropriati per minimizzarne l'impatto sulla vita dei pazienti. Maggiori informazioni sulla campagna e sulla condizione sono disponibili su LifeDisRPted.com.
Kiniksa Pharmaceuticals (Nasdaq: KNSA) se ha asociado con Carly Pearce, una cantautora galardonada con un GRAMMY, para expandir su campaña Life DisRPted™, centrada en aumentar la conciencia sobre la pericarditis recurrente. La campaña tiene como objetivo promover el diagnóstico temprano y el tratamiento de esta rara enfermedad autoinflamatoria crónica. Pearce, quien fue diagnosticada con pericarditis recurrente mientras estaba de gira en mayo de 2024, se une a la iniciativa para apoyar a los pacientes y cuidadores afectados por esta condición.
La campaña sirve como una plataforma para animar tanto a pacientes como a proveedores de salud a reconocer los signos de pericarditis recurrente y desarrollar planes de tratamiento apropiados para minimizar su impacto en la vida de los pacientes. Más información sobre la campaña y la condición se puede encontrar en LifeDisRPted.com.
키니크사 제약 (Nasdaq: KNSA)는 그래미 수상 가수이자 송라이터인 칼리 피어스와 협력하여 재발성 심낭염에 대한 인식을 높이는 Life DisRPted™ 캠페인을 확장하였습니다. 이 캠페인은 이 희귀하고 만성적인 자가염증 질환의 조기 진단 및 치료를 촉진하는 것을 목표로 하고 있습니다. 2024년 5월 투어 중 재발성 심낭염 진단을 받은 피어스는 이 질환에 영향을 받은 환자와 간병인을 지원하기 위해 이 이니셔티브에 참여하고 있습니다.
캠페인은 환자와 의료 제공자가 재발성 심낭염의 징후를 인식하고 환자의 삶에 미치는 영향을 최소화하기 위한 적절한 치료 계획을 개발하도록 장려하는 플랫폼 역할을 합니다. 캠페인 및 질환에 대한 더 많은 정보는 LifeDisRPted.com에서 확인할 수 있습니다.
Kiniksa Pharmaceuticals (Nasdaq: KNSA) a établi un partenariat avec Carly Pearce, chanteuse-compositrice primée aux GRAMMY, pour élargir sa campagne Life DisRPted™, qui vise à sensibiliser au sujet de la péricardite récurrente. La campagne a pour objectif de promouvoir un diagnostic et un traitement précoces de cette maladie auto-inflammatoire chronique rare. Pearce, qui a été diagnostiquée avec une péricardite récurrente lors d'une tournée en mai 2024, rejoint l'initiative pour soutenir les patients et les aidants touchés par cette condition.
La campagne sert de plateforme pour encourager les patients et les professionnels de santé à reconnaître les signes de la péricardite récurrente et à élaborer des plans de traitement appropriés afin de minimiser son impact sur la vie des patients. Plus d'informations sur la campagne et la condition peuvent être trouvées sur LifeDisRPted.com.
Kiniksa Pharmaceuticals (Nasdaq: KNSA) hat sich mit GRAMMY-gewinnerin Carly Pearce zusammengetan, um die Life DisRPted™-Kampagne auszubauen, die das Bewusstsein für wiederkehrende Perikarditis schärfen soll. Ziel der Kampagne ist es, eine frühzeitige Diagnose und Behandlung dieser seltenen chronischen autoinflammatorischen Erkrankung zu fördern. Pearce, die im Mai 2024 während einer Tournee mit wiederkehrender Perikarditis diagnostiziert wurde, unterstützt die Initiative, um Patienten und Pflegepersonen zu begleiten, die von dieser Erkrankung betroffen sind.
Die Kampagne dient als Plattform, um sowohl Patienten als auch Gesundheitsdienstleister zu ermuntern, Anzeichen von wiederkehrender Perikarditis zu erkennen und angemessene Behandlungspläne zu entwickeln, um deren Auswirkungen auf das Leben der Patienten zu minimieren. Weitere Informationen zur Kampagne und zur Erkrankung finden Sie auf LifeDisRPted.com.
- None.
- None.
– National campaign to elevate experiences from the recurrent pericarditis community and empower patients to seek care –
LONDON, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) (Kiniksa), a commercial-stage biopharmaceutical company, with a pipeline of immune-modulating assets designed to target a spectrum of cardiovascular and autoimmune diseases, today announced a partnership with GRAMMY Award-winning singer-songwriter, Carly Pearce, as part of its Life DisRPted campaign focused on promoting early diagnosis and treatment of recurrent pericarditis. Pearce announced that she had been diagnosed with the chronic autoinflammatory disease while on tour in May 2024.
“We are excited to have Carly Pearce join our Life DisRPted campaign in support of the patients and caregivers facing recurrent pericarditis, a rare, chronic, flaring disease that is too often undertreated,” said Sanj K. Patel, Chairman and Chief Executive Officer of Kiniksa. “With this campaign, we continue to provide a clear call to action for both patients and healthcare providers to seek out the signs of recurrent pericarditis and develop a treatment plan to minimize the impact it has on patient lives.”
To learn about recurrent pericarditis and the Life DisRPted campaign, visit LifeDisRPted.com.
About Recurrent Pericarditis
Recurrent pericarditis is a painful and debilitating chronic autoinflammatory cardiovascular disease marked by inflammation of the pericardium and is often associated with changes in electrical conduction and sometimes buildup of fluid around the heart, called pericardial effusion. Recurrent pericarditis symptoms have an impact on quality of life, limit physical activities, and lead to frequent emergency department visits and hospitalizations. Data show that approximately 40,000 patients in the U.S. seek and receive treatment for recurrent pericarditis each year. Of that group, approximately 14,000 patients experience two or more recurrences due to persistent underlying disease or inadequate response to conventional therapies, such as nonsteroidal anti-inflammatory drugs (NSAIDs), colchicine and corticosteroids.
About Kiniksa
Kiniksa is a commercial-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Kiniksa’s immune-modulating assets are based on strong biologic rationale or validated mechanisms, target a spectrum of underserved cardiovascular and autoimmune conditions, and offer the potential for differentiation. For more information, please visit www.kiniksa.com.
About Carly Pearce
Fiercely rooted in the classics, GRAMMY® Award-winning singer-songwriter Carly Pearce lit a fire with her debut album Every Little Thing and the PLATINUM-certified history-making title track, and she hasn’t slowed down since. With the praised release of her highly anticipated fourth album, hummingbird (June 7, Big Machine Records), Pearce continues to resonate with her honest lyrics and timeless musicality. The critically acclaimed album includes lead single “we don’t fight anymore” (featuring Chris Stapleton), which earned Pearce her second GRAMMY® nomination for Best Country Duo/Group Performance and fifth Top 5 Country Radio hit. Pearce is currently performing the new music on her headlining hummingbird world tour. Previously, her critically acclaimed and commercially lauded third studio album 29 produced Country Radio chart toppers including “Never Wanted To Be That Girl” with Ashley McBryde which gave Pearce her second consecutive ACM Music Event of the Year in 2022 and marked the third duet between two solo women to top Billboard’s Country Airplay chart. The song also took home the 2022 CMA Musical Event of the Year and won a GRAMMY® Award for Best Country Duo/Group Performance, marking Pearce’s first, and making history as the first female pairing to win in the category. In addition, Pearce’s 3x PLATINUM-certified “I Hope You’re Happy Now" with Lee Brice won both the 2020 CMA Awards Musical Event and 2021 ACM Awards Music Event, plus ACM Single of the Year. Both a Grand Ole Opry and Kentucky Music Hall of Fame member, Pearce has since made her 100th performance at the Grand Ole Opry. For more information, visit CarlyPearce.com.
Every Second Counts! ®
Kiniksa Investor Contact
Jonathan Kirshenbaum
(781) 829-3949
jkirshenbaum@kiniksa.com
Kiniksa Media Contact
Tyler Gagnon
(781) 431-9100
tgagnon@kiniksa.com
Carly Pearce Media Contacts
Erica Gerard
erica.gerard@fullcoverage.com
Avery Robinson
avery.robinson@fullcov.com
FAQ
What is the purpose of Kiniksa's Life DisRPted campaign with Carly Pearce?
When was Carly Pearce diagnosed with recurrent pericarditis?
How can patients learn more about Kiniksa's (KNSA) Life DisRPted campaign?
What type of disease is recurrent pericarditis according to KNSA's campaign?
